Bain Capital Life Sciences Fund II, L.P. 13D and 13G filings for Mersana Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-15 4:45 pm Purchase |
2024-11-13 | 13D | Mersana Therapeutics, Inc. MRSN |
Bain Capital Life Sciences Fund II, L.P. | 4,968,006 4.000% |
926,273 (+22.92%) |
Filing |
| 2022-05-11 5:26 pm Unchanged |
2022-05-09 | 13D | Mersana Therapeutics, Inc. MRSN |
Bain Capital Life Sciences Fund II, L.P. | 4,041,733 4.200% |
0 (Unchanged) |
Filing |
| 2022-04-14 4:56 pm Purchase |
2022-04-13 | 13D | Mersana Therapeutics, Inc. MRSN |
Bain Capital Life Sciences Fund II, L.P. | 4,041,733 4.800% |
747,310 (+22.68%) |
Filing |
| 2022-02-08 5:02 pm Unchanged |
2022-02-07 | 13D | Mersana Therapeutics, Inc. MRSN |
Bain Capital Life Sciences Fund II, L.P. | 3,294,423 4.400% |
0 (Unchanged) |
Filing |
| 2022-01-03 5:10 pm Unchanged |
2021-12-29 | 13D | Mersana Therapeutics, Inc. MRSN |
Bain Capital Life Sciences Fund II, L.P. | 3,294,423 4.500% |
0 (Unchanged) |
Filing |
| 2021-01-12 5:19 pm Purchase |
2021-01-08 | 13D | Mersana Therapeutics, Inc. MRSN |
Bain Capital Life Sciences Fund II, L.P. | 3,294,423 4.800% |
222,857 (+7.26%) |
Filing |